new glp 1 agonist for weight loss Top GLP-1 Agonists Balance Efficacy, Safety GLP-1 agonists are part of

RCTs evaluating GLP-1 RA have not identified indicators of suicidality

New mechanisms for weight loss are continually being explored, offering new potential drug targets from cannabinoid receptor blockers, nucleotide-binding domain, leucine-richcontaining family, pyrin domaincontaining-3 (NLRP3) inhibitors, free fatty acid receptor 2 (FFA2) inhibitors and gene-editing RNA therapy

Diabetes 58 , 975983 (2009)

Structural modulation of the gut microbiota and the relationship with body weight: compared evaluation of liraglutide and saxagliptin treatment

Accordingly, the scientific community has taken an interest in studying other potential uses for these drugs, possibly including PCOS, Alzheimers, Parkinsons addiction, liver disease, and even some types of cancer

New risks include increased aspiration risk during anesthesia due to delayed gastric emptying and challenges with bowel preparation for colonoscopies [50] [51] [52]